Literature DB >> 7356508

Hyperthermic peritoneal perfusion system in canines.

J S Spratt, R A Adcock, W Sherrill, S Travathen.   

Abstract

The thermal infusion filtration system was designed to manage malignant effusions and treat metastatic cancers of the intracavitary serosa. Hyperthermia, chemotherapy, and cell and debris filtration were administered by a dynamic fluid flow. Preclinical evaluations of surgical procedure, temperature studies, fluid dynamics, and physiology were carried out in 15 dogs (17.2 to 25.4 kg) with peritoneal perfusion at 41 degrees C and 10 liters/hr flow. Results suggest that the dynamics of flow achieves total intracavitary equilibrium in 7 min. The time essential to elevate animal body mass temperature from ambient to 41 degrees varied as a function of mass. The hyperthermia induced expected nonlethal responses in physiology. The system was determined to be safe for clinical procedure.

Entities:  

Mesh:

Year:  1980        PMID: 7356508

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

Review 1.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 2.  [Hyperthermic intraperitoneal chemotherapy].

Authors:  H Leebmann; P Piso
Journal:  Chirurg       Date:  2019-07       Impact factor: 0.955

Review 3.  Multimodal treatment of gastric cancer in the west: Where are we going?

Authors:  Daniele Marrelli; Karol Polom; Giovanni de Manzoni; Paolo Morgagni; Gian Luca Baiocchi; Franco Roviello
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

4.  Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites.

Authors:  Mingchen Ba; Hui Long; Xiangliang Zhang; Yunqiang Tang; Yinbing Wu; Feihong Yu; Shuai Wang; Shuzhong Cui
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-22       Impact factor: 4.553

5.  Intraperitoneal approach to regional hyperthermia--possible anticancer applications.

Authors:  G V Smith; R MacMillan; J Stribling
Journal:  World J Surg       Date:  1983-11       Impact factor: 3.352

6.  Peritoneal carcinomatosis of colorectal origin.

Authors:  Antonio Macrì; Edoardo Saladino; Vincenzo Bartolo; Vincenzo Adamo; Giuseppe Altavilla; Epifanio Mondello; Giovanni Condemi; Angelo Sinardi; Ciro Famulari
Journal:  World J Gastrointest Oncol       Date:  2010-02-15

Review 7.  Intraperitoneal immunotherapy: historical perspectives and modern therapy.

Authors:  W F Morano; A Aggarwal; P Love; S D Richard; J Esquivel; W B Bowne
Journal:  Cancer Gene Ther       Date:  2016-11-11       Impact factor: 5.987

8.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant disease.

Authors:  Wenceslao Vásquez Jiménez; Luis González Bayón; José Luis García-Sabrido; Santiago González Moreno
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

9.  Surgical management of carcinomatosis from colorectal cancer.

Authors:  Paul H Sugarbaker
Journal:  Clin Colon Rectal Surg       Date:  2005-08

Review 10.  Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective.

Authors:  Madalyn G Neuwirth; H Richard Alexander; Giorgos C Karakousis
Journal:  J Gastrointest Oncol       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.